Izumi et al. (2022) found that CD133 is preferentially downregulated in the cytoplasm by p62-mediated selective autophagy/lysosomal degradation to control CD133 levels in neuroblastoma cells that exhibit high basal autophagy activity [112]. This evidence concerns the gene PROM1 and neuroblastoma.